ArticleSisli Etfal Hastanesi tip bulteni2025
Management of AQUAfilling® Filler Application Complications.
Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the use of AQUAfilling® filler has become widespread, particularly in breast and gluteal augmentation, which are among the most common aesthetic surgical procedures. Although AQUAfilling® filler is claimed to be biocompatible with human tissue, the number of complications associated with it continues to increase. The invasion of AQUAfilling® filler into the parenchyma, as well as the toxicity and oncogenicity of its main component, polyacrylamide, remain uncertain and require further investigation. In this study, we present three female patients with a history of AQUAfilling® filler injection for breast and gluteal augmentation who experienced long-term major complications. We aim to emphasize the significance of long-term complications of AQUAfilling® filler material and contribute to the reconstruction options in managing these complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.